Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Eur Urol Focus. 2017 Jun 3;5(2):242–249. doi: 10.1016/j.euf.2017.05.006

Figure 2.

Figure 2

Figure 2

Propensity score-adjusted overall survival curves according to the study group (PC-LND: green line; No PC-LND: red line) and extent of lymph node metastases (pelvic lymph nodes: thick line; retroperitoneal lymph nodes: thin line); without (2A) and with (2B) a 3-month landmark.

Abbreviations: LN: lymph nodes; PC-LND: postchemotherapy lymph node dissection; RP: retroperitoneal.